Viridian Therapeutics News

RBC Capital Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Maintains Target Price $44

Futu NewsSep 19 19:31

Wedbush Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $45

Futu NewsSep 14 00:31

Viridian Therapeutics Analyst Ratings

BenzingaSep 13 21:55

RBC Capital Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $44

Futu NewsSep 13 19:33

RBC Capital Keeps Their Buy Rating on Viridian Therapeutics (VRDN)

TipRanksSep 13 18:51

Buy Rating Affirmed for Viridian Therapeutics Following Positive THRIVE Study Results and Strong Market Potential for Veli

TipRanksSep 13 13:59

Goldman Sachs Maintains Buy on Viridian Therapeutics, Raises Price Target to $31

BenzingaSep 12 23:47

Goldman Sachs Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $31

Futu NewsSep 12 22:32

B.Riley Financial Maintains Viridian Therapeutics(VRDN.US) With Hold Rating, Raises Target Price to $22

Futu NewsSep 12 03:31

B. Riley Adjusts Viridian Therapeutics Price Target to $22 From $20, Maintains Neutral Rating

MT NewswiresSep 12 02:15

A Quick Look at Today's Ratings for Viridian Therapeutics(VRDN.US), With a Forecast Between $27 to $56

Futu NewsSep 11 21:00

Oppenheimer Reaffirms Their Buy Rating on Viridian Therapeutics (VRDN)

TipRanksSep 11 19:50

Viridian Therapeutics Is Maintained at Buy by Needham

Dow JonesSep 11 19:16

Buy Rating Affirmed for Viridian Therapeutics on Successful THRIVE Trial and Market Potential

TipRanksSep 11 19:08

Critical Insights From Viridian Therapeutics Analyst Ratings: What You Need To Know

BenzingaSep 11 04:03

Viridian Therapeutics Price Target Maintained With a $27.00/Share by HC Wainwright & Co.

Dow JonesSep 11 01:53

Viridian Therapeutics Analyst Ratings

BenzingaSep 10 23:45

BTIG Research Adjusts Viridian Therapeutics Price Target to $56 From $46, Maintains Buy Rating

MT NewswiresSep 10 23:32

Buy Rating for Viridian Therapeutics Backed by Positive Clinical Results and Strong Market Prospects

TipRanksSep 10 22:37

Wedbush Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Maintains Target Price $42

Futu NewsSep 10 20:31